Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25299218 | 1.00 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL421993 | 0.97 | APP (0.50) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL4731267 | 0.94 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL20875302 | 0.94 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL2191721 | 0.94 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL19640302 | 0.94 | APP (0.48) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL263732 | 0.92 | APP (0.46) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL18380848 | 0.92 | APP (0.46) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL8384077 | 0.91 | MEN1 (0.50) | APPPTGS1PDE4ALMNASLC6A6 | |
| SCHEMBL29437894 | 0.91 | MEN1 (0.50) | APPPTGS1PDE4ALMNASLC6A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118086987-A | Copper electroplating solution and preparation method thereof | 苏州捷得宝机电设备有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20200207744-A1 | DIMER COMPOUNDS, AND USE IN BINDING TOXIC REPEATS OF RNA | EXPANSION THERAPEUTICS, INC. | 2020-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200207744-A1 | DIMER COMPOUNDS, AND USE IN BINDING TOXIC REPEATS OF RNA | HNRNPH1, HNRNPUL2, HNRNPH3 | APP 2211/4885PTGS1 4429/4885PDE4A 4343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.